Loading...
Images of Tomohiro Kuwayama
(0 from 0 )Network Profiles
LinkedIn: Tomohiro Kuwayama | LinkedIn
Tomohiro Kuwayamaさんのプロフィールをチェックしましょう。LinkedInは、Tomohiro Kuwayamaさんのような方が活動する世界最大の ...
Facebook: Tomohiro Kuwayama Profiles | Facebook
View the profiles of people named Tomohiro Kuwayama on Facebook. Join Facebook to connect with Tomohiro Kuwayama and others you may know. Facebook gives people the
Business Profiles
patentbuddy: Tomohiro Kuwayama
NGK SPARK PLUG CO., LTD., Kasugai-shi, JP
Education
Effect of ONO on Bone Mineral Density and Biochemical Markers of...
kclpure.kcl.ac.uk
author = "Richard Eastell and Shinichi Nagase and Maria Small and Steven Boonen and Tim Spector and Michiyo Ohyama and Tomohiro Kuwayama and Steve ...
Related Documents
Bone turnover markers and pharmacokinetics of a new ...dokumen.tips › Documents
dokumen.tips
... Small John Sharpe Junichiro Manako Tomohiro Kuwayama Steve DeaconReceived: 25 September Accepted: 5 December The ...
Publications
Publications Authored by Tomohiro Kuwayama | PubFacts
www.pubfacts.com
Publications Authored by Tomohiro Kuwayama
Bone turnover markers and pharmacokinetics of a new sustained-release...
rd.springer.com
Tomohiro Kuwayama. Drug Development ONO PHARMA UK LTD; Steve Deacon. Drug Development ONO PHARMA UK LTD; Original Article. First Online: 24 January …
Miscellaneous
Tomohiro Kuwayama | LinkedIn
www.linkedin.com
View Tomohiro Kuwayama's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Tomohiro Kuwayama discover ...
MP SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE AND...
www.infona.pl
Deacon · Details · Authors · Fields of science ... Tomohiro Kuwayama · see all ...
ONO Pharma UK Ltd. - Companies Londonwww.companieslondon.com › ono-pharma-uk-ltd
www.companieslondon.com
Secretary Name, Tomohiro Kuwayama. Nationality, British. Status, Resigned. Appointed, 18 June 2004(6 years, 4 months after company formation).
Study of ONO in Patients With Overactive Bladder | RxWiki
www.rxwiki.com
Study of ONO in Patients With Overactive Bladder: Official Title: A Randomised, ... Study Director: Tomohiro Kuwayama Clinical Development, ONO Pharma UK, Ltd:
US A1 - Ceramic junction member, ceramic heater and gas...
patents.google.com
A ceramic joining unit, ceramic heater and gas sensor, the ceramic joining unit including: a ceramic base member; an electrode pad provided on a surface...
Phase II Multi-centre, Extension Study to Investigate the Long ...trialbulletin.com › lib › entry
trialbulletin.com
Ltd. Provider of Information About this Clinical Study. Sponsor. Overall Official(s). Tomohiro Kuwayama, Study Director, Ono Pharma UK.
Controlled Study of ONO in Postmenopausal Women With Osteopenia...
clinicaltrialsfeeds.org
The purpose of this study is to evaluate the efficacy and safety of ONO in postmenopausal women with osteopenia or osteoporosis.
Clinical trial: Placebo Controlled Study of ONO2506PO in the Presence...
www.druglib.com
20 Jun Sponsored by: Ono Pharma. Official(s) and/or principal investigator(s): Tomohiro Kuwayama, Study Director, Affiliation: Ono Pharma UK, Ltd. ...
Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in...
clinicaltrials.gov
Study Director: Tomohiro Kuwayama, Ono Pharma UK, Ltd. More Information. No publications provided. Responsible Party: Development ...
Related search requests for Tomohiro Kuwayama
| Mikio Nishii Haru Sano |
People Forename "Tomohiro" (600) Name "Kuwayama" (31) |
sorted by relevance / date